Celastrol inhibits pro-inflammatory cytokine secretion in Crohn’s disease biopsies
- 24 September 2004
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 322 (3), 778-786
- https://doi.org/10.1016/j.bbrc.2004.07.186
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Points of control in inflammationNature, 2002
- Redox regulation of pro-inflammatory cytokines and IκB-α/NF-κB nuclear translocation and activationBiochemical and Biophysical Research Communications, 2002
- TNF-R1 Signaling: A Beautiful PathwayScience, 2002
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- Genes, Microbes, and T Cells — New Therapeutic Targets in Crohn's DiseaseThe New England Journal of Medicine, 2002
- Signal Transduction and the Control of Gene ExpressionScience, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Prostaglandin E2 Upregulates Cyclooxygenase-2 Expression in Lipopolysaccharide-Stimulated RAW 264.7 MacrophagesBiochemical and Biophysical Research Communications, 2000
- Activation of nuclear factor kappa B in inflammatory bowel diseaseGut, 1998
- Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease.Gut, 1992